Lexaria Gets Attention with GLP-1 Test on Deck
Lexaria Bioscience Corp. will open for normal Nasdaq trading on Tuesday after closing Friday at $0.65. Shares climbed 7.33% in the last full session before the Memorial Day holiday. Regular trading restarts at 9:30 a.m. Eastern, with pre-market open at 4 a.m. Lexaria’s move is now in focus as its next test takes aim at the fast-growing oral obesity drug space. GLP-1 medicines that copy a gut hormone for hunger and blood sugar are a big market, dominated by Novo Nordisk and Eli Lilly.